Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Step by step instructions to Contrast Lab Jewels and Regular Ones - 2Knesset FADC extends emergency draft for 280,000 IDF reservists until January 1
- 3Best Disney Palace: Which One Catches Your Creative mind?
- 4How to watch the last supermoon of the year
- 5Mom finds out she has cancer after noticing something was off while breastfeeding
- 10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
- German foreign minister heads to China to talk rare-earth exports
- Best Amusement Park Bite: What Do You Very much want to Crunch On?
- The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices
- This St Nick Truly Can Advise How To Drink And Hack Your Headache
- Email Promoting Instruments for Compelling Efforts
- She was the ultimate '90s fitness influencer. Now she's delivering Uber Eats — and rebuilding her life.
- Do-It-Yourself Home Style on a Careful spending plan: Imaginative Thoughts and Tasks
- MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts
